Delian Zhang
Overview
Explore the profile of Delian Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
277
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ma H, Cai X, Zhang D, Zhu Q, Wu T, Aierken X, et al.
Am J Transl Res
. 2025 Feb;
17(1):585-602.
PMID: 39959243
Objectives: Polyarteritis nodosa (PAN) is a rare autoimmune disease that can cause severe functional impairment. Early diagnosis and timely intervention are essential to reduce disease severity and improve outcomes. Methods:...
2.
Shen D, Cai X, Hu J, Song S, Zhu Q, Ma H, et al.
J Inflamm Res
. 2025 Feb;
18:1623-1638.
PMID: 39925928
Objective: Hypertension development and progression are largely influenced by inflammation, which plays a critical role by activating the immune system and causing damage to the vascular endothelium. Metabolic dysfunction-associated fatty...
3.
Maitituersun A, Heizhati M, Li N, Gan L, Li M, Yao L, et al.
BMC Public Health
. 2024 Oct;
24(1):2705.
PMID: 39367430
No abstract available.
4.
Shen D, Cai X, Hu J, Song S, Zhu Q, Ma H, et al.
Front Endocrinol (Lausanne)
. 2024 Oct;
15:1451383.
PMID: 39363897
Objective: To explore the link between plasma aldosterone concentration (PAC) and the prevalence of metabolic dysfunction-related fatty liver disease (MAFLD) in hypertensive patients. Methods: We analyzed data from 41,131 hospitalized...
5.
Maiturouzi M, Zhu Q, Zhang D, Luo Q, Wang M, Cai X, et al.
Eur J Endocrinol
. 2024 Aug;
191(2):262-270.
PMID: 39166829
Objective: Previous studies focusing on primary aldosteronism (PA) and thyroid diseases were controversial. Hence, this study aimed to examine associations between thyroid function, thyroid diseases, and PA and its subtypes....
6.
Song S, Cai X, Hu J, Zhu Q, Shen D, Ma H, et al.
Front Endocrinol (Lausanne)
. 2024 Aug;
15:1424207.
PMID: 39140032
Background: Prior research has highlighted the association between uric acid (UA) and the activation of the renin-angiotensin-aldosterone system (RAAS). However, the specific relationship between aldosterone, the RAAS's end product, and...
7.
Li N, Zhu Q, Dang Y, Zhou Y, Cai X, Heizhati M, et al.
Rev Cardiovasc Med
. 2024 Jul;
25(3):104.
PMID: 39076957
Background: The accurate identification and diagnosis of secondary hypertension is critical,especially while cardiovascular heart disease continues to be the leading cause of death. To develop a big data intelligence platform...
8.
Zhao J, Cai X, Hu J, Song S, Zhu Q, Shen D, et al.
Diabetes Metab Syndr Obes
. 2024 Jul;
17:2671-2681.
PMID: 38978818
Background: A newly introduced obesity-related index, the weight-adjusted-waist index (WWI), emerges as a promising predictor of cardiovascular disease (CVD). Given the known synergistic effects of hypertension and obstructive sleep apnea...
9.
Song S, Cai X, Hu J, Zhu Q, Shen D, Ma H, et al.
Drug Des Devel Ther
. 2024 Jun;
18:2215-2225.
PMID: 38882049
Objective: While the role of aldosterone in bone metabolism is well established, the specific effects of the widely used aldosterone antagonist, spironolactone, on bone health are not fully understood. This...
10.
Maitituersun A, Heizhati M, Li N, Gan L, Li M, Yao L, et al.
BMC Public Health
. 2024 May;
24(1):1370.
PMID: 38773424
Background: Aldosterone plays important parts in development of cardio-metabolic diseases as end product of renin-angiotensin-aldosterone system. However, factors elevating circulating aldosterone are not clear, and lifestyle-related factors are suggested to...